Nature-based bioreactors: Tackling antibiotic resistance in urban wastewater treatment

The overuse and misuse of antibiotics have accelerated the selection of antibiotic-resistant bacteria, significantly impacting human, animal, and environmental health. As aquatic environments are vulnerable to antibiotic resistance, suitable management practices should be adopted to tackle this phen...

Descripción completa

Detalles Bibliográficos
Autores: Bertrans-Tubau, Lluís, Martínez Campos, Sergio, Lopez Doval, Julio, Abril, Meritxell, Ponsá Salas, Sergio, Salvadó, Victoria, Hidalgo, Manuela, Pico-Tomàs, Anna, Balcazar, José Luis, Proia, Lorenzo
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:UVic-UCC
Repositorio:RiUVic. Repositori institucional de la UVic-UCC
OAI Identifier:oai:dnet:riuvic______::807ba36f2c50dbc7f4c14cdb310c9c44
Acceso en línea:http://hdl.handle.net/10854/180989
https://doi.org/10.1016/j.ese.2024.100445
Access Level:acceso abierto
Palabra clave:Biofilms
574
Descripción
Sumario:The overuse and misuse of antibiotics have accelerated the selection of antibiotic-resistant bacteria, significantly impacting human, animal, and environmental health. As aquatic environments are vulnerable to antibiotic resistance, suitable management practices should be adopted to tackle this phenomenon. Here we show an effective, nature-based solution for reducing antibiotic resistance from actual wastewater. We utilize a bioreactor that relies on benthic (biofilms) and planktonic microbial communities to treat secondary effluent from a small urban wastewater treatment plant (<10,000 population equivalent). This treated effluent is eventually released into the local aquatic ecosystem. We observe high removal efficiency for genes that provide resistance to commonly used antibiotic families, as well as for mobile genetic elements that could potentially aid in their spread. Importantly, we notice a buildup of sulfonamide (sul1 and sul2) and tetracycline (tet(C), tet(G), and tetR) resistance genes specifically in biofilms. This advancement marks the initial step in considering this bioreactor as a naturebased, cost-effective tertiary treatment option for small UWWTPs facing antibiotic resistance challenges